We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3711:TWSEASE Technology Holding Co., Ltd. Analysis

Data as of 2026-06-20 - not real-time

NT$613.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: ASE trades at 613 TWD, comfortably above its 20‑day (591), 50‑day (528.6) and 200‑day (318.7) moving averages, indicating a bullish price trend. However, the MACD histogram is negative and the signal line is bearish, RSI sits at 60 (approaching overbought), volume is declining, and the 30‑day volatility is a high 75%, all under an Extreme Greed market sentiment (fear‑greed index 91.46) and a beta above 1.2, suggesting heightened short‑term risk.
Fundamental outlook: Revenue is growing at 17% YoY with forward EPS projected to more than double (24.35 vs 10.18 trailing), compressing the forward P/E to ~25 versus a trailing P/E of 60 and an industry average of 38. The DCF‑derived fair value (~645 TWD) is modestly above the current price, yet analysts’ target range (≈572‑576 TWD) implies expectations of a correction. The balance sheet shows a debt‑to‑equity of 67% and negative free cash flow, raising concerns about dividend sustainability (1.07% yield, payout ~52%). Strategic moves—AI‑driven advanced packaging demand and a new collaboration with WUS Printed Circuit—provide a growth catalyst, but leverage and cash‑flow constraints temper the upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with bearish MACD divergence
  • Decreasing volume and elevated volatility
  • Current valuation above analyst targets

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and accelerating forward EPS
  • AI‑driven advanced packaging demand
  • Strategic partnership expanding manufacturing capacity

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained secular growth in semiconductor packaging
  • High leverage and negative free cash flow limiting flexibility
  • Dividend sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth17.20%
Profit Margin7.04%
P/E Ratio60.2
ROE13.58%
ROA4.23%
Debt/Equity67.16
P/B Ratio7.7
Op. Cash FlowNT$158.7B
Free Cash FlowNT$-66127527936
Industry P/E38.1

Technical Analysis

TrendBullish
RSI60.0
SupportNT$520.00
ResistanceNT$669.00
MA 20NT$591.00
MA 50NT$528.60
MA 200NT$318.72
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair ValueNT$644.74
Target PriceNT$575.75
Upside/Downside-6.08%
GradeFair
TypeBlend
Dividend Yield1.07%

Risk Assessment

Beta1.26
Volatility75.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.